Similar to our results, Varghese et al. reported that the deficiency of the glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme in PPP, could promote PAH development (18). The gene discussed is G6PD; the disease is pulmonary arterial hypertension.